BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Atomwise

Atomwise logo

Founded
2012
Patents
8
Publications
22

Technologies

AI Companies (Drug Discovery) Pharmaceutical and Drug Discovery

Atomwise uses Deep Learning Neural Networks to help discover new medicines. Atomwise achieves the world’s best results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, startups, and research institutions.

drug discovery deep learning


Posts Mentioning This Company

9 Companies Using Artificial Intelligence to Fight Infectious Diseases

  
Development of a novel drug is a tedious process that requires immense investments of resources and time - on average, it takes at least ten years and $ 2.6 B for a new medicine to complete the journey from initial discovery to the marketplace. And then patents give pharmaceutical companies …

Toronto’s Blossoming AI-driven Drug Discovery Scene

  
Canada has established itself as a rapidly growing global hub for artificial intelligence (AI) innovation and commercialization. This roots deep into the history of early programs and funding provided by Canadian Institute for Advanced Research (CIFAR) and the Natural Sciences and Engineering Research Council of Canada (NSERC) to such AI …

Contract Research Organizations Tap Into AI To Increase Value Proposition

  
A few decades ago, pharmaceutical giants did most of the discovery work in-house, along with every other work necessary to get a drug or medical device to market. Nowadays, nearly any type of R&D or regulatory filing work that a drug maker or a medical-device producer needs to do -- …

Pharmaceutical Giants Are Chasing R&D Deals With Smaller AI Startups

  
The first month of 2019 is not over yet, but there are already four major announcements about new research projects between large drug discovery corporations and smaller artificial intelligence (AI) companies -- this is more than the number of all similar announcements in the year 2014 combined -- only three.

How Big Pharma Adopts AI To Boost Drug Discovery

  
(Last updated 08.10.2018) The type of artificial intelligence (AI) which scares some of the greatest minds, like Elon Musk and Stephen Hawking, is called “general artificial intelligence” -- the one which can “think” pretty much like humans do, and which can quickly evolve into a dangerous “superintelligence”. There is a …

2018 Brings A Surge Of Activity In The “AI For Drug Discovery” Space

  
(Last updated: 15.03.2018) The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate of pharmaceutical research programs has inspired a notable amount of activity over the last several years with a considerable number of initiated research collaborations between AI-driven R&D vendors and top …
SHARE